The coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in Wuhan city and was declared a pandemic in March 2020. Although the virus is not restricted to the lung parenchyma, the use of chest ...
China was the epicenter for the novel coronavirus disease (COVID-19), which quickly spread to other Asian countries and later to Western countries; subsequently, COVID-19 was categorized as a pandemic by the World Health Organization. Diagnosis primarily depends on viral detection in respiratory samples; however, available kits are limited, lack high sensitivity, and have a long turnaround time for providing results. In this scenario, computed tomography has emerged as an efficient and available high-sensitivity method, allowing radiologists to readily recognize findings related to COVID-19. The objective of this article is to demonstrate the main tomographic findings in symptomatic respiratory patients with COVID-19 to assist medical professionals during this critical moment.
1 January 2020 in Jornal Brasileiro de Pneumologia
To determine the correlation between the two tomographic classifications for coronavirus disease (COVID-19), COVID-19 Reporting and Data System (CORADS) and Radiological Society of North America Expert Consensus Statement on Reporting Chest Computed Tomography ...
Objective To evaluate the role of chest computed tomography in patients with COVID-19 who presented initial negative result in reverse transcriptase-polymerase chain reaction (RT-PCR). Methods A single-center, retrospective study that evaluated 39 patients with negative RT-PCR for COVID-19, who underwent chest computed tomography and had a final clinical or serological diagnosis of COVID-19. The visual tomographic classification was evaluated according to the Consensus of the Radiological Society of North America and software developed with artificial intelligence for automatic detection [...] ABSTRACT Objective To evaluate the role of chest computed tomography in patients with COVID-19 who presented initial negative result in reverse transcriptase-polymerase chain reaction (RT-PCR). Methods A single-center, retrospective study that evaluated 39 patients with negative RT-PCR for COVID-19, who underwent chest computed tomography and had a final clinical or serological diagnosis of COVID-19. The visual tomographic classification was evaluated according to the Consensus of the Radiological Society of North America and software developed with artificial intelligence for automatic detection
A 34-year-old woman with a personal history of ulcerative rectocolitis for 5 years who were using sulphasalazine and mesalazine. The patient was admitted to the emergency unit presenting asthenia, dyspnea, fever, cough with hemoptoic sputum for 8 days, and oxygen saturating by 97% in room air. The computed tomography (CT) () showed sparse ground-glass opacities, although more evident in the posterior contour of lower lobes. She was hospitalized and tested positive for coronavirus infection identified through real-time reverse-transcription-polymerase-chain-reaction (RT-PCR) test. [...] A 34-year-old woman with a personal history of ulcerative rectocolitis for 5 years who were using sulphasalazine and mesalazine. The patient was admitted to the emergency unit presenting asthenia, dyspnea, fever, cough with hemoptoic sputum for 8 days, and oxygen saturating by 97% in room air. The computed tomography (CT) () showed sparse ground-glass opacities, although more evident in the posterior contour of lower lobes. She was hospitalized and tested positive for coronavirus infection identified through real-time reverse-transcription-polymerase-chain-reaction (RT-PCR) test.